"The head of Marlboro cigarette-maker Philip Morris International (PMI) has hit out at critics of a controversial swoop on a healthcare company, claiming that the acquisition will help achieve its target to make the UK smoke-free within a decade. In the wake of fierce opposition to the deal to buy FTSE 250 inhaler-maker Vectura, André Calantzopoulos, PMI’s executive chairman, said the “obsessive focus” by anti-smoking campaigners on Big Tobacco was the “wrong approach”, adding that PMI has the “ability and the technology” to address harm from smoking.
The Sunday Times's Sabah Meddings told her readers to 'buy' shares of international conference and events organiser Hyve.
Important Legal Notice about News Sources: Pilling and Co Stockbrokers Ltd. is not responsible for the content or accuracy of third party news and we may not share the views of the author or publisher. We provide third party news for your convenience and information only and make no representation or endorsement whatsoever and hereby exclude all liability for any loss or damage that may be incurred by you as a result of your access or use. Please note that third party content may be subject to terms and conditions imposed by the third party owner of that content.